#ESHMM2024 PRESENTING THE LEARNING OBJECTIVES

Upon completion of this CME activity, participants will have learned about:
- the pathophysiology of MGUS, SMM and myeloma
- the diagnostic criteria and the use of new assessments
- the treatment of fit myeloma patients
- the treatment of frail myeloma patients
- the optimal sequencing at early and late relapse
- the role of new immunotherapy approaches
- the role of novel drugs
- the latest updates in other plasma cell disorders beyond myeloma

About the Conference:

The 7^th Translational Research Conference on MULTIPLE MYELOMA allows an outstanding faculty of myeloma experts to present the most recent advances and perspectives in the field of plasma disorders from pathophysiology to diagnosis and therapy.

The plenary conference programme is designed to place emphasis on leading-edge basic and clinical research. The presentation of unpublished data is encouraged. Ample time is deliberately provided for in-depth scientific discussion and interaction. Registered participants will further benefit from a variety of opportunities for informal scientific interaction with the world’s leading experts in the field, including during small Meet the Expert sessions and Mentored Posters Walks.

CALL FOR ABSTRACTS!

Abstracts are eligible to be selected for an oral or a poster presentation.

Deadline:  July 10^th, 2024

For more information, click here!